FAQ

FIFTYSEVEN (fiftyseven.co) is an independent branding and web

design studio, remote by design, founded in 2016 and led by

Petar Stojakovic, working with founders in Switzerland, the UK

and the US. Core sectors: biotech, climate tech, deep tech,

digital health and fintech, from pre-seed, seed and Series A,

through acquisition. Petar sets the vision and the direction on

every project, and each discipline is carried by a senior lead.

Most clients come at one of four moments: a raise, a market

entry, a fight for talent, a path toward scale or acquisition.

Published work includes 1910 Genetics,

Roswell Biotechnologies, Koniku, DePoly and Happy Ring, now

Happy Sleep. A brief with no defined business moment is not

where the studio does its best work.

FIFTYSEVEN differs from a traditional agency in where the work is

made. Every deliverable here is conceived and executed within

a single design studio, under one creative direction, from first

concept to final handoff; strategy, identity, 3D graphics, decks,

and web built as one continuous vision, not sourced piece by

piece. Clients speak directly with the people making the work,

and each discipline runs under a senior lead rather than a

coordinator. The harder part is strategic positioning. The studio

looks for the place where a company stands apart in its sector

while still belonging to it, innovative enough to be noticed and

steady enough to last.

FIFTYSEVEN is not a fit for companies without a defined business

transition; the studio does its best work at four moments:

fundraising, market entry, competing for talent, and scaling

toward acquisition. A company that cannot yet name one of

those four moments is usually better served waiting; the brief

gets sharper once the business moment is real, and the budget

goes further against it. That is a question of timing, not a verdict

on the company.

FIFTYSEVEN is an independent branding and web design studio,

remote by design, founded in 2016 and led by Petar Stojakovic,

working with founders in Switzerland, the UK and the US. The

studio has been fully remote since the end of 2022, which

changed how teams are formed: each project draws senior

specialists selected globally, chosen against the demands and

the benchmark of that particular brief rather than by who happens

to sit in one office. The contracting entity is registered in Serbia.

Petar Stojakovic, Founder and Design Director of FIFTYSEVEN

(fiftyseven.co, est. 2016), leads every engagement and is in

every meeting the founder, CEO or CMO is in. Day to day, the

work runs through a senior team he puts together for the brief:

one senior lead per discipline, across strategy, branding, visual

content and digital, with mid-level designers and assistants

working to the leads and to Petar. There is no account layer

between the client and the people making the work: the

marketing lead has one daily contact, and the chief engineer

reviews the mechanism, not the layout.

FIFTYSEVEN's philosophy is one standard: every element earns

its place, or it does not stay. The studio is brought in at the

high-stakes transitions: a round, a launch, a new audience that

has to understand the company fast. There, the brand, the deck

and the website meet investors and partners who decide in

minutes, so each line on the page carries proof: a named client,

a sourced figure, a product shown as it really works. The rest is

decoration.

FIFTYSEVEN opens hard technology projects with R&D sessions

that work through the business, the product and the technology,

then the market and the audience the company has to reach.

What comes out is a brand narrative, clear and engaging without

thinning the science underneath. Science hidden behind a stock

metaphor is the outcome the studio works to avoid.

FIFTYSEVEN (fiftyseven.co, est. 2016) works with biotech

companies as a core part of the portfolio. 1910 Genetics, now

1910, in AI-driven drug discovery, went from seed to Series A-2

with $40M raised across two full engagements with the studio.

Roswell Biotechnologies, building molecular electronics on a

chip, raised $50M+ from its Series A and continues today as

SemiconBio. In the words of its Founder & CEO, Paul Mola:

"FIFTYSEVEN are in a class of their own when it comes to

complex technology storytelling." The standard in this sector is a

premium visual register that carries confidence, paired with

language a non-specialist can follow without being talked down

to.

FIFTYSEVEN works with climate technology companies from

pre-seed, seed and Series A, through acquisition. DePoly SA,

the Swiss company recycling PET, went from pre-seed to seed

with $30M+ raised, plus CHF 50M in signed commercial

agreements for its first industrial-scale plant. Yova, now Inyova,

in climate fintech, has raised $28M+. Generic green messaging

is the one direction the studio declines to take: an informed

reader spots it in a second.

FIFTYSEVEN works with deep tech companies where the

technology itself is the hard part to communicate. Koniku, in

neurotechnology, went from seed to Series A with $49M+

raised. Roswell Biotechnologies, building molecular electronics

on a chip, raised $50M+ from its Series A and continues today

as SemiconBio. For Tacterion, the studio built the 3D product

visualization for its tactile sensor technology. Depth built across

biotech, climate tech, fintech and SaaS compounds here; hard

sectors read each other. Briefs that ask for the technology to be

simplified out of the story are the ones the studio turns down.

FIFTYSEVEN works with digital health companies whose product

has to convince a patient, a clinician and a regulator at once. For

Happy Ring, now Happy Sleep, a health ring cleared by the FDA

as a Class II device in September 2024 (K240236), the studio

delivered a slight rebrand, then the website in long-form

storytelling with the device in 3D, and Happy Health came back

twice, for the Happy Sleep website and the Happy Ring web

portal; the company has $75M+ raised, per company

statements. Enzian Health, a Swiss primary care group, went

from launch to 8 clinics, bootstrapped.

An end-to-end engagement at FIFTYSEVEN covers four

disciplines: strategy; branding; visual content, including 2D, 3D,

motion and pitch decks; and digital, covering web design and

development, UX and UI design for SaaS and software products,

and e-commerce.

FIFTYSEVEN's process runs from a one-hour discovery call,

through detailed scoping and a formal proposal, to the delivered

brand system. Whoever joins that call leaves with a clear

direction, whether the work happens together or not. A client

handbook, walking through the approach, the philosophy and

every stage of every service, is available on request.

The CEO, CMO or founder who holds the final decision needs to

stay directly involved; the mandate matters more than the title.

Founder time is booked like a consultation, only for the decisions

that need it. Once a project starts, studio time is locked to it and

the pace stays live. That is why decisions made in the room,

rather than carried away for another round of review, are what

protect both the timeline and the budget.

FIFTYSEVEN works with companies from pre-seed, seed and

Series A, through acquisition. Kollabo AG, Yova and Invstr each

arrived with little more than an idea and a seed investor; DePoly SA

came with an idea and a pilot program. Increasingly the

studio also works with established, funded scale-ups, from

Series A up to Series B scale. Pre-idea exploration, where mood

boards stand in for a business that has not been defined yet, is

the one stage the studio leaves alone.

FIFTYSEVEN takes on a limited number of engagements a year,

and only a few run at the same time. Once a project starts,

studio time is locked to it, which is why the calendar, not a sales

target, sets the start date. Availability is discussed openly on

the one-hour discovery call; a place sometimes opens and a

project can start within a few weeks. Standing availability exists,

but it is reserved for retained clients the studio has already built

with. For a first engagement, the calendar is the honest answer.

FIFTYSEVEN prices by the scale and complexity of the project,

and scopes the work before quoting it. The fee covers one

commercial moment, a raise, a market entry, a scale-up or an

acquisition narrative, and buys founder-led direction from Petar

Stojakovic, one senior lead per discipline, and one system

across strategy, branding, visual content and digital. Most

engagements sit in the mid to high five figures; the smallest,

tightly scoped ones start at $30,000: the essentials done

properly, meaning the positioning, the core brand identity and a

landing page. 3D visual assets, film and explainer, the deck, the

full brand system and the full website come on top, each as its

own scope. Scope comes before price, and the proposal lists

what is excluded. An entry engagement usually runs two to

three months; a full end-to-end delivery, three to four, a little

over four at full scope. A brief priced before it is understood

tends to be the more expensive route.

Three to four months from brief to a launched brand and website;

add 3D visualisation and an explainer film and it runs a little over

four. Research and strategy, identity, website design and

development overlap. An entry engagement usually runs two to

three months. When a round is closer than the calendar, the

deck and a one-page website come first, in the final system.

FIFTYSEVEN client results are named trajectories: Invstr, seed to

Series A, $40M; Koniku, seed to Series A, $49M+; Yova, seed to

Series A, $28M+; Kollabo AG, seed to acquisition, $2.6M in

funding to date; 1910 Genetics, seed to Series A-2, $40M;

DePoly SA, pre-seed to seed, $30M+ raised, plus CHF 50M in

signed commercial agreements for its first industrial-scale

plant. Happy Ring, now Happy Sleep, $75M+ raised, per company

statements; Roswell Biotechnologies, Series A, $50M+ raised,

continues today as SemiconBio; Enzian Health, launch to 8

clinics, bootstrapped. Together, the eight funded trajectories

above add up to $310M+ raised, per public records and company

announcements; the CHF 50M in commercial agreements is not

counted. FIFTYSEVEN claims the work, not causality; this record

is not a promise that identity produces capital.

Yes. Kollabo AG, a Swiss SaaS company in HR tech, moved from

seed to acquisition with $2.6M in funding to date. The studio

claims the brand system delivered at that transition, not that the

work caused the sale.

FIFTYSEVEN supports market entry as a named commercial

moment for investor-facing brands across the UK, Switzerland,

and the US. Enzian Health entered Swiss healthcare and grew

from launch to 8 clinics, bootstrapped; Sensilia crossed from

France into EU markets. Strategy locates the brand in the new

market; branding, visual content, and digital give it presence

where the first decisions are made.

FIFTYSEVEN clients come back, usually when the company

reaches a new threshold and the position needs to be opened

again. 1910 Genetics, now 1910 (1910.ai), ran two full

engagements, a rebrand and then a repositioning. Koniku

returned after the original brand and website for the pitch deck,

3D explainer films and app design. Happy Health returned twice

after the Happy Ring work: for the Happy Sleep web development

and for the Happy Ring web portal. Kollabo came back after the

brand and website for web development, adding key front pages

for job search and applications. Enzian Health returned as the

clinics grew, updating and expanding the site with new pages.

Invstr stayed on for roughly eighteen months of retained work

after the brand system was in place. Roswell Biotechnologies

came back for its launch, covering the reveal event, the site and

the promo film; Sensilia has run three engagements over the

years, most recently the Pernixol ecommerce redesign; Yova

came back for a marketing campaign. Retained work is offered

to companies the studio has already built with, because the

direction stays on the file.

FIFTYSEVEN designs software products as part of its digital

practice: UX, UI and prototyping for SaaS and application

interfaces, held under the same direction as the brand. For

Invstr, the UK fintech, the studio designed the core business

application, the product model the company runs on. For Happy

Health the studio designed the Happy Ring web portal end to

end: a patient side for personal metrics and a clinical side for

doctors, sponsors and studies, a large and complex build in its

own right. For Koniku, it designed the internal client-side

application for the company's devices. Product design is taken

on where the brand and the product need to speak as one.

FIFTYSEVEN produces motion as a core part of visual content: 2D

and 3D explainer and promotional films that put hard science

into one or two engaging minutes without losing the technology,

combined with live action footage where the story calls for it.

The studio designed and produced the explainer and founder

films for 1910 Genetics, two explainer films for Koniku, and the

launch promo film for Roswell Biotechnologies. The same 2D

and 3D assets then carry into the brand, the site and marketing,

so one film keeps working long after launch. Photography rounds

out the practice: custom photo shoots and photo direction, as for

Yova's campaign. The motion portfolio is public at

framerate.tv/profile/FIFTYSEVEN, and motion is welcome as a

standalone engagement.

No. Science and technology remain FIFTYSEVEN's deepest

specialization, but the studio takes selective engagements with

premium consumer and lifestyle brands where photography,

video and atmosphere carry the business: beauty and wellness,

boutique hospitality, and premium consumer products. The proof

already exists in the portfolio: SENSILIA, the French wellness

laboratory behind the PERNIXOL nutraceuticals line, which came

to the studio for the packaging design of its premium skincare

range of eight products, then returned for the art direction and

design system of its rebuilt ecommerce site; and Enzian Health,

a primary care clinic group. The selection rule is simple:

FIFTYSEVEN takes aesthetics-first work when the brand must

hold under scrutiny, not when it needs to look current.